FDA clears KARL STORZ’s RUBINA Lens for use in open surgery

KARL STORZ has received clearance from the FDA for its RUBINA Lens exoscope, authorising its use for open surgery. The RUBINA Lens is intended for real-time tissue perfusion assessment, lymphatic mapping, and breast surgery. The RUBINA Lens enables surgeons to switch between standard and NIR imaging using indocyanine green for added information. Credit: MAD.vertise / Shutterstock.com. KARL STORZ has received clearance from the US Food and Drug Administration (FDA) for its RUBINA Lens exoscope, authorising its use for open surgery. The exoscope offers digital, camera-based imaging and extends the company’s near-infrared (NIR) imaging options to both open and minimally invasive…

Source: Medical Device Network